Company Filing History:
Years Active: 2005
Title: Albrecht Bufe: Innovator in Allergy Therapy
Introduction
Albrecht Bufe is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of immunotherapy, particularly in the area of allergy treatment. His innovative work focuses on developing modified recombinant allergens that can improve the efficacy of allergy therapies.
Latest Patents
Albrecht Bufe holds a patent for "Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same." This invention relates to modified recombinant allergen mutants derived from natural raw materials, such as pollen. These allergens stimulate lymphocytes from allergic patients to proliferate and synthesize cytokines while exhibiting a reduced ability to bind to IgE antibodies. This characteristic makes them suitable for specific, tailored allergy therapies.
Career Highlights
Albrecht Bufe is associated with Merck Patent Gesellschaft MIT, where he continues to advance his research and innovations. His work has the potential to significantly impact the treatment of pollen allergies, providing patients with more effective therapeutic options.
Collaborations
Albrecht has collaborated with notable colleagues, including Helga Kahlert and Hans-Thomas Stüwe. Their combined expertise contributes to the development of innovative solutions in the field of allergy treatment.
Conclusion
Albrecht Bufe's contributions to immunotherapy represent a significant advancement in allergy treatment. His patented work on modified recombinant allergens showcases his commitment to improving patient outcomes in allergy therapy.